Reports Q4 revenue $5.0B, consensus $4.98B. “We had a solid finish to 2023, delivering strong organic growth as well as cost and earnings recovery above our initial expectations,” said CEO Mike Hsu. “Our Q4 results demonstrate topline momentum with more balanced growth across volume, mix and price led by strong Personal Care results. I’m proud of our team’s outstanding execution, including enhancing the value proposition of our global brands through consumer-centric innovation and stronger, more integrated commercial capabilities. We enter 2024 having advanced the company’s strategic foundation and financial position, and with confidence this phase of cost recovery and supply chain stabilization is largely behind us. Moving forward, we will continue to invest in differentiating our brands and enhancing our capabilities while we maintain a disciplined cost structure in our next phase of growth. I’m confident we are positioned to accelerate and enhance the performance of our business and create meaningful shareholder value as we deliver our purpose of better care for a better world.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KMB:
- Kimberly Clark (KMB) Q4 Earnings Cheat Sheet
- Kimberly-Clark price target raised to $125 from $119 at JPMorgan
- Kimberly-Clark price target raised to $128 from $123 at Barclays
- Kimberly-Clark price target raised to $130 from $128 at Deutsche Bank
- The beauty and wellness stocks to own in 2024, according to Piper Sandler